Added to YB: 2026-02-25
Pitch date: 2025-12-17
MDLN [bullish]
Medline Inc.
+31.04%
current return
Author Info
No bio for this author
Company Info
Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally.
Market Cap
$41.4B
Pitch Price
$38.15
Price Target
63.00
Dividend
N/A
EV/EBITDA
16.99
P/E
687.61
EV/Sales
2.08
Sector
Health Care Equipment and Supplies
Category
growth
Medline Inc. - $MDLN
MDLN: Largest Med-Surg provider, vertically integrated low-cost supplier w/ 49% private label (25% EBITDA margin) vs 5% on 3rd party distribution. 14% rev CAGR L10Y, never declined YOY since 1966. 18% ROIC, ~100% FCF conversion. PL penetration upside from 10% to 60% in Prime Vendor contracts = $4B rev/$1B gross profit. Price target $63 (20%+ IRR 3-5yr). IPO at $29 (13.7x 2026 EBITDA) vs peers 13.8x, potential re-rating to 15-16x. Risks: tariff pressure on margins through 1H26.
Read full article (12 min)